HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nonprofit Pharmaceutical Companies

503.398

-20.475-3.91%

Number of Gainers:8

Number of Losers:24

Number of Flat:1

PE:- -

High:523.582

Open:523.582

Low:498.297

Close:523.873

Volume:119.87M

Turnover:3.20B

Market Cap:322.68B

Float Cap:286.07B

Loading ...

Alphamab Oncology - Board Resolves to Repurchase Shares up to HK$80 Mln in Value

THOMSON REUTERS

Alphamab Oncology Launches On-Market Share Buyback of up to HK$ 80 Million

EDDING GENOR Reports Interim Loss, Swinging to Deficit in First Half

China's Zhaoke Ophthalmology H1 Revenue Rises

Suzhou Basecare FY26 H1 Net Loss Narrows 40.7% to RMB 72.05 Million; Revenue Rises 27% to RMB 128.75 Million

Zhaoke Ophthalmology FY26 H1 Loss Widens to RMB 122.59 Million; Revenue Rises 19.14% to RMB 18.83 Million

Mabpharm FY26 H1 Profit More than Doubled to RMB 31.36 Million; Revenue Rises 45.1% to RMB 397.94 Million

Edding Genor Swings to FY26 H1 Net Loss of RMB 65.88 Million; Revenue Falls 23.1% to RMB 872.73 Million

Domestic Innovative Drug Sector Shifts From Cash Burn to Profit Generation as Mid-Year Reports Roll In

ZyLoxTB Allocates HK$1.16M to Buy Back 53,000 Shares on August 28

CStone Pharmaceuticals (SEHK:2616) Stock Price Reflects Growth While Losses Stay Heavy

Simply Wall St.

Zylox-Tonbridge Files HKEX Next-Day Disclosure Return Reporting Share Repurchase at HKD 21.78-22.2

Alphamab Oncology (SEHK:9966) Stock Rally Meets Revenue Dip And Losses

Simply Wall St.

Goldman Sachs Lifts Innocare Price Target to HK$22.71 on Robust Orelabrutinib Sales

AH Premium Rankings for August 28: NE Electric Leads, CATL Records Negative Premium

Sweden's Elicera Therapeutics Q2 Loss Widens

InnoCare Pharma (SEHK:9969) Could Be 24% Undervalued Following Profit Turn

Simply Wall St.

Fosun Chairman Guo Guangchang: Staying the Course on Core Sectors Like Pharma with R&D Spend of RMB 4.2 Billion in H1, Up 16.7%

Akeso Says Phase III Ivonescimab-Chemo Trial in Biliary Tract Cancer Meets Overall Survival Endpoint

Zhongjing Wanxi Pharma Donates One Million Yuan to Quake-Hit Gyirong in Tibet

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/BK1574/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"Nonprofit Pharmaceutical Companies","latestPrice":503.39795,"timestamp":1788163726135,"preClose":523.8731,"halted":0,"volume":119868273,"delay":0,"changeRate":-0.039084,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-20.475159,"latestTime":"08-31 16:00:00","open":523.582,"high":523.582,"low":498.29733,"amount":3203299214.5,"amplitude":0.048265,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788226200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1788139800000,1788148800000],[1788152400000,1788163200000]],"pbRate":3.909696,"peRate":137.956161,"turnoverRate":0.003654,"increases":8,"decrements":24,"flats":1,"marketCap":322680201168,"floatMarketCap":286067329608},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":523.582,"amplitude":0.048265,"preClose":523.8731,"low":498.29733,"pbRate":"3.909696","latestPrice":503.39795,"volume":119868273,"delay":0,"open":523.582,"prevYearClose":556.26263,"prevWeekClose":523.873,"prevMonthClose":503.398,"prevQuarterClose":453.519,"fiveDayClose":496.742,"twentyDayClose":467.18,"sixtyDayClose":475.465,"secType":"PLATE","market":"HK","turnoverRate":0.003654,"peRate":137.956161,"marketCap":322680201168,"floatMarketCap":286067329608,"timestamp":1788163726135,"nameCN":"Nonprofit Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":8,"down":24,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662096191","title":"Alphamab Oncology - Board Resolves to Repurchase Shares up to HK$80 Mln in Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2662096191","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662096191?lang=en_us&edition=fundamental","pubTime":"2026-08-28 21:56","pubTimestamp":1787925376,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nFWN44P1XZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","09966","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662509616","title":"Alphamab Oncology Launches On-Market Share Buyback of up to HK$ 80 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662509616","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662509616?lang=en_us&edition=fundamental","pubTime":"2026-08-28 21:55","pubTimestamp":1787925346,"startTime":"0","endTime":"0","summary":"Alphamab Oncology launches on-market share buyback of up to HK$ 80 millionAlphamab Oncology authorized an on-market share buyback of up to HK$80 million, starting Aug. 28, 2026.Repurchases will be fun","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL21zqMG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171474901","title":"EDDING GENOR Reports Interim Loss, Swinging to Deficit in First Half","url":"https://stock-news.laohu8.com/highlight/detail?id=1171474901","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171474901?lang=en_us&edition=fundamental","pubTime":"2026-08-28 21:50","pubTimestamp":1787925016,"startTime":"0","endTime":"0","summary":"EDDING GENOR (06998) has announced its financial results for the six-month period ended June 30, 2026, revealing a notable shift from profitability to a net loss.During the reporting period, the...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","06998","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662951720","title":"China's Zhaoke Ophthalmology H1 Revenue Rises","url":"https://stock-news.laohu8.com/highlight/detail?id=2662951720","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662951720?lang=en_us&edition=fundamental","pubTime":"2026-08-28 21:24","pubTimestamp":1787923484,"startTime":"0","endTime":"0","summary":"China's Zhaoke Ophthalmology H1 revenue risesOverviewChina ophthalmic drug maker's interim revenue rose yr/yr to RMB 18.8 mlnNon-HKFRS adjusted loss for the period widened slightly to RMB 116.1 mlnCom","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL1N44P0JF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1209","BK1589","BK1191","BK1583","03692","BK1574","BK1161","02219","02616","BK1587","06622"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662951250","title":"Suzhou Basecare FY26 H1 Net Loss Narrows 40.7% to RMB 72.05 Million; Revenue Rises 27% to RMB 128.75 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662951250","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662951250?lang=en_us&edition=fundamental","pubTime":"2026-08-28 21:23","pubTimestamp":1787923391,"startTime":"0","endTime":"0","summary":"Suzhou Basecare FY26 H1 net loss narrows 40.7% to RMB 72.05 million; revenue rises 27% to RMB 128.75 millionSuzhou Basecare posted revenue of RMB 128.75 million for the six months ended June 30, 2026,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL9lJSRM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02170","BK1574","BK1597","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662696095","title":"Zhaoke Ophthalmology FY26 H1 Loss Widens to RMB 122.59 Million; Revenue Rises 19.14% to RMB 18.83 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662696095","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662696095?lang=en_us&edition=fundamental","pubTime":"2026-08-28 21:16","pubTimestamp":1787923002,"startTime":"0","endTime":"0","summary":"Zhaoke Ophthalmology FY26 H1 loss widens to RMB 122.59 million; revenue rises 19.14% to RMB 18.83 millionZhaoke Ophthalmology posted revenue of RMB 18.83 million, up 19.14% for the six months ended Ju","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL4x0NrM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06622","BK1191","BK1583","BK1574","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662409300","title":"Mabpharm FY26 H1 Profit More than Doubled to RMB 31.36 Million; Revenue Rises 45.1% to RMB 397.94 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662409300","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662409300?lang=en_us&edition=fundamental","pubTime":"2026-08-28 21:05","pubTimestamp":1787922358,"startTime":"0","endTime":"0","summary":"Mabpharm FY26 H1 profit more than doubled to RMB 31.36 million; revenue rises 45.1% to RMB 397.94 millionMabpharm posted a swing to profit, with attributable earnings of RMB 31.36 million, versus RMB ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDLc92Mfg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02181","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662098078","title":"Edding Genor Swings to FY26 H1 Net Loss of RMB 65.88 Million; Revenue Falls 23.1% to RMB 872.73 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662098078","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662098078?lang=en_us&edition=fundamental","pubTime":"2026-08-28 20:40","pubTimestamp":1787920807,"startTime":"0","endTime":"0","summary":"Edding Genor swings to FY26 H1 net loss of RMB 65.88 million; revenue falls 23.1% to RMB 872.73 millionEdding Genor posted a net loss of RMB 65.88 million, swinging from profit in the year-earlier per","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL71J8MG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","06998","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126390441","title":"Domestic Innovative Drug Sector Shifts From Cash Burn to Profit Generation as Mid-Year Reports Roll In","url":"https://stock-news.laohu8.com/highlight/detail?id=1126390441","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126390441?lang=en_us&edition=fundamental","pubTime":"2026-08-28 20:30","pubTimestamp":1787920254,"startTime":"0","endTime":"0","summary":"As August draws to a close, the release of mid-year reports from innovative drug companies is accelerating, drawing heightened attention to the sector. How did domestic innovative drug developers...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159992","BK1161","LNGR","06978","IBBQ","MEDX","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174722178","title":"ZyLoxTB Allocates HK$1.16M to Buy Back 53,000 Shares on August 28","url":"https://stock-news.laohu8.com/highlight/detail?id=1174722178","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174722178?lang=en_us&edition=fundamental","pubTime":"2026-08-28 20:28","pubTimestamp":1787920091,"startTime":"0","endTime":"0","summary":"ZYLOXTB (02190) announced on August 28 that it spent HK$1.163 million to repurchase 53,000 shares of its own stock.According to the company's statement, the buyback transaction was executed on the...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1587","02190","BK1100","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662933470","title":"CStone Pharmaceuticals (SEHK:2616) Stock Price Reflects Growth While Losses Stay Heavy","url":"https://stock-news.laohu8.com/highlight/detail?id=2662933470","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662933470?lang=en_us&edition=fundamental","pubTime":"2026-08-28 20:26","pubTimestamp":1787919973,"startTime":"0","endTime":"0","summary":"CStone Pharmaceuticals came into this print with its stock up 35.4% over the past month and another move to HK$5.89 into the close on 28 August. That price action reflects a growth story that investors already know is not yet profitable. The headline from these half year numbers is the size of the earnings hole. CStone reported a net loss of ¥252.3m for H1 2026 and trailing 12 month losses from continuing operations of ¥419.1m. The market is paying up for forecast growth while the income...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2616/cstone-pharmaceuticals-shares/news/cstone-pharmaceuticals-sehk2616-stock-price-reflects-growth","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2616/cstone-pharmaceuticals-shares/news/cstone-pharmaceuticals-sehk2616-stock-price-reflects-growth","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["02616","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662060331","title":"Zylox-Tonbridge Files HKEX Next-Day Disclosure Return Reporting Share Repurchase at HKD 21.78-22.2","url":"https://stock-news.laohu8.com/highlight/detail?id=2662060331","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662060331?lang=en_us&edition=fundamental","pubTime":"2026-08-28 19:50","pubTimestamp":1787917803,"startTime":"0","endTime":"0","summary":"Zylox-Tonbridge files HKEX next-day disclosure return reporting share repurchase at HKD 21.78-22.2Zylox-Tonbridge filed an HKEX next-day disclosure return showing a repurchase of 53,000 H shares on Au","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDLrVW9h:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","02190","BK1100","BK1587","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662935380","title":"Alphamab Oncology (SEHK:9966) Stock Rally Meets Revenue Dip And Losses","url":"https://stock-news.laohu8.com/highlight/detail?id=2662935380","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662935380?lang=en_us&edition=fundamental","pubTime":"2026-08-28 19:32","pubTimestamp":1787916728,"startTime":"0","endTime":"0","summary":"Alphamab Oncology stock has been on a short run higher, with the shares up about 15% over the past month. However, today’s earnings send a very different message. The headline is simple: revenue for the first half of 2026 came in at ¥271.2m, while the company reported a net loss of ¥40.5m and a basic loss per share of ¥0.04.\nFor a biotech that still trades on revenue potential more than profit, this contrast between top line and continuing losses is what the market is really reacting to. The...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9966/alphamab-oncology-shares/news/alphamab-oncology-sehk9966-stock-rally-meets-revenue-dip-and","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9966/alphamab-oncology-shares/news/alphamab-oncology-sehk9966-stock-rally-meets-revenue-dip-and","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["VOTE","PMDE","RGLO","09966","DECU","BK1574","BK1161","FEBU","GXDW","VGFPF","JOYT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163785274","title":"Goldman Sachs Lifts Innocare Price Target to HK$22.71 on Robust Orelabrutinib Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=1163785274","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163785274?lang=en_us&edition=fundamental","pubTime":"2026-08-28 16:40","pubTimestamp":1787906422,"startTime":"0","endTime":"0","summary":"Goldman Sachs has released a research report raising its earnings per share forecasts for INNOCARE (09969) for the 2026 to 2028 period, from 0.15, 0.05, and 0.32 yuan to 0.16, 0.08, and 0.37 yuan,...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE0002270589.USD","IE00B19Z3581.USD","LU1144417596.USD","LU1894683264.USD","688428","LU0096364046.USD","09969","LU0106831901.USD","LU1804176565.USD","LU1868836757.USD","LU1894683348.USD","LU2237438978.USD","LU0742534661.SGD","LU0868494617.USD","LU0345770308.USD","BK1161","IE00B19Z3B42.SGD","LU2237443895.HKD","LU1868837300.USD","LU2237443978.SGD","LU2265009873.SGD","BK0239","IE00BFXG1179.USD","LU1791807156.HKD","GS","LU1868837136.USD","EWH","LU1868836914.USD","BK4127","BK4550","IE0034235188.USD","LU0868494708.USD","LU0345770993.USD","BK4588","LU2237443382.USD","LU0942090050.USD","LU2237443465.HKD","LU2237443622.USD","IE00BSNM7G36.USD","LU0251142724.SGD","LU2471134879.HKD","IE0004086264.USD","LU2471134796.USD","LU2750360997.AUD","BK1574","LU2237443549.SGD","BK4504","LU0210536198.USD","BK4533","LU2471134952.CNY","LU2896262040.SGD","IE0004091025.USD","LU0048573561.USD","GSX","BK4516","LU2471134523.USD","LU0061475181.USD","BK4552","LU0251131958.USD","LU2750360641.GBP","LU1868836591.USD","LU1668664300.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137057087","title":"AH Premium Rankings for August 28: NE Electric Leads, CATL Records Negative Premium","url":"https://stock-news.laohu8.com/highlight/detail?id=1137057087","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137057087?lang=en_us&edition=fundamental","pubTime":"2026-08-28 16:21","pubTimestamp":1787905307,"startTime":"0","endTime":"0","summary":"As of the close of trading on August 28, the latest A-H share premium data has been released, offering a comprehensive snapshot of the valuation gap between dual-listed stocks. The rankings highlight...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1190","BK1530","LU2394011477.USD","LU0821914370.USD","LU0516422440.USD","BK1193","LU0320764755.SGD","LU1244550494.USD","BK1144","BK1205","BK1514","LU0348825331.USD","IE00B5MMRT66.SGD","IE00BF5LJ272.USD","LU1675838814.USD","LU0082770016.SGD","LU1813983027.USD","LU2476274720.SGD","LU1251922891.USD","BK1505","LU1188198961.HKD","03308","LU0588546209.SGD","LU2177674079.SGD","BK1554","LU0672654166.SGD","LU0648948544.HKD","LU0165289439.USD","LU0791591158.USD","BK1231","LU0456827905.SGD","LU1688375341.USD","BK1546","HK0000352291.HKD","BK1507","LU0039217434.USD","LU0082770016.USD","BK1116","LU0329678337.USD","LU1655091616.SGD","HK0000352382.USD","LU0048580855.USD","LU0449509016.USD","LU0287142896.SGD","LU0307460666.USD","LU1328277881.USD","LU2476274308.USD","LU0327786744.USD","LU0862451753.SGD","06821","LU0708995583.HKD","LU1244550577.SGD","LU0244354667.USD","BK1198","02727","03908","LU1115378108.SGD","LU0231483743.USD","IE00BZ08YT58.USD","LU0329678170.USD","LU0516423091.SGD","LU1105468828.SGD","LU0054450605.USD","BK1594","LU0516423174.USD","HK0000252152.HKD","03750","LU0828237510.HKD","LU0029875118.USD","02359","LU0348766576.USD","LU0449515922.USD","BK1209","SG9999002463.SGD","LU1719994722.HKD","BK1583","IE00B3M56506.USD","HK0001040168.HKD","LU1282649810.SGD","SG9999001093.SGD","LU0106959298.USD","LU0043850808.USD","LU0890818403.SGD","LU0589944569.HKD","LU0516422366.SGD","LU1366334578.USD","IE0008368742.USD","LU0228367735.SGD","HK0000306685.HKD","LU0918141887.USD","BK1523","BK1506","LU0463099449.HKD","LU0049853897.USD","LU0181495838.USD","IE00B29SXG58.USD","BK1610","02338","BK1544","LU0149721374.USD","BK1562","LU0228659784.USD","LU0096374516.USD","LU0620787316.HKD","LU0266512127.USD","LU3063872942.SGD","LU0823426480.USD","BK1533","LU1961090484.USD","LU2045819591.USD","BK1105","LU0315179316.USD","IE00BVYPNQ40.USD","HK0000252160.HKD","SG9999006597.SGD","LU1224709979.USD","LU1152091754.HKD","LU0269904917.USD","03328","LU0531970944.HKD","BK1551","LU0456846285.SGD","LU0501845795.SGD","LU0320764599.SGD","BK1592","LU0828238088.HKD","LU1046422090.SGD","LU0531971595.HKD","LU0345780521.USD","LU1808992512.USD","LU0572944931.SGD","LU2097828631.EUR","LU0348805143.USD","BK1161","LU1282649141.HKD","LU1008478684.HKD","LU1152091168.USD","LU1988902786.USD","LU0370786039.SGD","03296","159982","00300","LU2242644610.SGD","BK1515","LU0359201885.HKD","LU0348814723.USD","LU0229945570.USD","LU1064131342.USD","BK1574","BK1564","BK1122","00991","BK1576","00981","LU2097828805.USD","BK1249","LU0540923850.HKD","00187","LU0886674414.USD","IE00BMCWC346.EUR","BK1141","LU0328353924.USD","LU0456854461.SGD","LU1831875114.USD","LU0051755006.USD","LU0640798160.USD","LU0214875030.USD","BK1501","IE00BYV24P56.USD","LU0254981946.USD","03200","LU0791590937.USD","LU2008162690.USD","LU0737861699.HKD","IE00B0169L03.USD","LU1481107354.HKD","LU0828237940.HKD","LU0543330566.HKD","LU0314109678.HKD","EWH","LU1769817096.USD","IE00B543WZ88.USD","BK1202","BK1522","LU0211977185.USD","IE0031814852.USD","LU0117841782.USD","00317","LU0163747925.USD","BK1614","LU0871576103.HKD","HK0000320264.USD","LU2097828474.EUR","02475","BK1149","00916","LU0868486357.SGD","LU1880383366.USD","LU2264538146.SGD","LU1242518857.USD","LU1720050803.USD","BK1526","LU0106252389.USD","82846","LU1023057109.AUD","IE0034224299.USD","LU1769817179.HKD","LU2125910500.SGD","IE00BGHQDM52.EUR","BK1191","02846","BK1183","03986","SG9999014674.SGD","LU2778985437.USD","HK0000500386.USD","LU0348827113.USD","LU0431992006.USD","01812","BK1558","BK1223","03678","HK0000306701.USD","LU2097828557.USD","LU1282649067.USD","83188","LU0067412154.USD","LU0797268264.HKD","LU0345780281.USD","LU0061477393.USD","IE0008369823.USD","06869","LU0266512473.USD","BK1516","HK0001040143.USD","01349","LU1303224171.USD","00638","LU0348767384.USD","83130","BK1560","02827","03130","LU2226246903.HKD","LU0072913022.USD","BK1147","LU2097828714.EUR","03143","LU0164939612.USD","LU0210526637.USD","01057","06185","LU1282648689.USD","LU0164880469.USD","BK1154","LU0052750758.USD","LU0348816934.USD","BK1125","SG9999004220.SGD","LU1226287529.USD","00568","LU0607220059.USD","399300","LU2399975544.HKD","LU1504937902.USD","LU1794554557.SGD","LU0516422952.EUR","LU0164865239.USD","IE00BZ08YR35.GBP","LU0543330483.HKD","LU0128522157.USD","03968","LU0348735423.USD","LU0979878070.USD","01033","LU0488056044.USD","LU1255011170.USD","LU0823040885.USD","02691","LU0326950275.SGD","SG9999002828.SGD","LU0348788117.USD","LU0509642566.USD","IE00B031J352.USD","LU1048596156.SGD","LU1993786604.SGD","01108","LU0359202008.SGD","02068","LU0417516902.SGD","LU0140636845.USD","BK1170","IE00BVYPNP33.GBP","LU0455707207.USD","LU0634319403.HKD","BK1214","BK1607","IE00BZ08YS42.EUR","01989","LU1244550221.USD","07233","LU1211504680.USD","LU0918141705.HKD","LU1770034418.SGD","LU0173614495.USD","LU0593848301.USD","IE00B031HY20.USD","03188","LU0384037296.USD","LU0149534421.HKD","LU0823426308.USD","IE0032431581.USD","LU0417516738.SGD","00553","00042","HK0000320223.HKD","LU1960683339.HKD","LU0561508036.HKD","LU0359201612.USD","LU1366334651.USD","BK1171","LU0469268626.HKD","SG9999011746.SGD","LU0502904849.HKD","BK1521","LU2294711473.HKD","LU2039709279.SGD","LU0880133367.SGD","LU1880383440.USD","BK1163","02899","LU0737861772.HKD","BK1148","LU1242518931.SGD","LU1807302812.USD","SG9999001226.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662513590","title":"Sweden's Elicera Therapeutics Q2 Loss Widens","url":"https://stock-news.laohu8.com/highlight/detail?id=2662513590","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662513590?lang=en_us&edition=fundamental","pubTime":"2026-08-28 14:12","pubTimestamp":1787897531,"startTime":"0","endTime":"0","summary":"Sweden's Elicera Therapeutics Q2 loss widensOverviewSweden CAR T-cell therapy developer's Q2 operating loss widened yr/yrLoss per share for Q2 increased to SEK -0.12 from SEK -0.06 yr/yrCompany raised","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL1N44P06L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1670711040.USD","LU1571399168.USD","BK4532","LU1868836591.USD","BK4007","LU1670710661.SGD","FTXH","LU1670710588.SGD","BK4581","LU0061475181.USD","LU0321505439.SGD","LU0882574055.USD","LU0225284248.USD","LU0432979614.USD","IE00BJT1NW94.SGD","LU1718418525.SGD","LU0114720955.EUR","LU1074936037.SGD","LU1032466523.USD","BK4588","LU2133065610.SGD","LU2242652126.USD","BK1583","LU0321505868.SGD","LU0985481810.HKD","LU1868836914.USD","IHE","BK1161","BMY","IE00B2B36J28.USD","LU2125154935.USD","BK4585","LU1291159041.SGD","LU1983299246.USD","LU2242646821.SGD","LU2360032135.SGD","LU0096364046.USD","LU0306807586.USD","LU0267386448.USD","LU0306806265.USD","LU1883839398.USD","BK4559","IE00BSNM7G36.USD","02126","LU1670711123.USD","LU1868837300.USD","IE0009355771.USD","BK1574","LU1585245621.USD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662063942","title":"InnoCare Pharma (SEHK:9969) Could Be 24% Undervalued Following Profit Turn","url":"https://stock-news.laohu8.com/highlight/detail?id=2662063942","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662063942?lang=en_us&edition=fundamental","pubTime":"2026-08-28 13:16","pubTimestamp":1787894202,"startTime":"0","endTime":"0","summary":"InnoCare Pharma (SEHK:9969) stock is in focus after the company reported a shift from loss to profit in the first half of 2026 and issued guidance to remain profitable for the full year.\nThe recent earnings swing to profit and guidance for higher EPS in the second half appear to have supported InnoCare Pharma’s share price, which has a 90 day share price return of 27.52% and a year to date share price return of 18.64%, against a 1 year total shareholder return that is down 12.04%.\nCompare...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/innocare-pharma-sehk9969-could-be-24-undervalued-following-p","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/innocare-pharma-sehk9969-could-be-24-undervalued-following-p","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["09969","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150078686","title":"Fosun Chairman Guo Guangchang: Staying the Course on Core Sectors Like Pharma with R&D Spend of RMB 4.2 Billion in H1, Up 16.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1150078686","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150078686?lang=en_us&edition=fundamental","pubTime":"2026-08-28 13:11","pubTimestamp":1787893863,"startTime":"0","endTime":"0","summary":"During the 2026 interim results conference held in Hong Kong on August 28, FOSUN INTL Chairman Guo Guangchang stated that the company's first-half performance was impressive, confirming that the \"fix...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159982","BK1574","159938","00656","BK1515","BK1230","09939","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662936058","title":"Akeso Says Phase III Ivonescimab-Chemo Trial in Biliary Tract Cancer Meets Overall Survival Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2662936058","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662936058?lang=en_us&edition=fundamental","pubTime":"2026-08-28 10:45","pubTimestamp":1787885130,"startTime":"0","endTime":"0","summary":"Akeso says Phase III ivonescimab-chemo trial in biliary tract cancer meets overall survival endpointAkeso highlighted late-stage gains for ivonescimab, with a Phase III first-line biliary tract cancer","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL6VxC1X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0561508036.HKD","LU1961090484.USD","LU2476274720.SGD","LU0348783233.USD","LU1720050803.USD","LU0348784397.USD","LU0348735423.USD","LU1794554557.SGD","IE00BPRC5H50.USD","LU0348766576.USD","LU0417516738.SGD","KURE","LU0348825331.USD","LU2399975544.HKD","BK1574","LU2488822045.USD","BK1161","LU0540923850.HKD","LU0348767384.USD","LU2778985437.USD","LU0348827113.USD","LU0634319403.HKD","LU0417516902.SGD","09926","IE00B543WZ88.USD","IE00B5MMRT66.SGD","LU0417516571.SGD","LU2476274308.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133942694","title":"Zhongjing Wanxi Pharma Donates One Million Yuan to Quake-Hit Gyirong in Tibet","url":"https://stock-news.laohu8.com/highlight/detail?id=1133942694","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133942694?lang=en_us&edition=fundamental","pubTime":"2026-08-28 10:03","pubTimestamp":1787882583,"startTime":"0","endTime":"0","summary":"On the morning of August 26, at around 10:30 AM, a debris flow triggered on the Nepalese side caused severe casualties and left people missing at the Gyirong Port in Gyirong County, Shigatse City,...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1574","01477"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":19,"pageCount":4,"totalSize":377,"code":"91000000","status":"200"}]}}